Pulmonary Arterial Hypertension

Gene: SMAD4

Red List (low evidence)

SMAD4 (SMAD family member 4)
EnsemblGeneIds (GRCh38): ENSG00000141646
EnsemblGeneIds (GRCh37): ENSG00000141646
OMIM: 600993, Gene2Phenotype
SMAD4 is in 25 panels

2 reviews

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Red List (low evidence)

DISPUTED by ClinGen.
Created: 8 Aug 2023, 6:15 a.m. | Last Modified: 8 Aug 2023, 6:15 a.m.
Panel Version: 1.32

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Pulmonary arterial hypertension MONDO:0015924, SMAD4-related

Bryony Thompson (Royal Melbourne Hospital)

I don't know

Comment on list classification: Disputed classification by ClinGen PH GCEP 21/11/2022
Created: 19 Jun 2023, 7:21 a.m. | Last Modified: 19 Jun 2023, 7:21 a.m.
Panel Version: 1.18
Comment on list classification: Two reported cases with PAH
Created: 28 Jan 2020, 12:54 a.m. | Last Modified: 28 Jan 2020, 12:54 a.m.
Panel Version: 0.36
A missense with reduced in vitro signalling activity and a putative splice site mutation resulting in moderate transcript loss due to compromised splicing efficiency were identified in two PAH cases.
Sources: Literature
Created: 28 Jan 2020, 12:54 a.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Phenotypes
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome MIM#175050; Pulmonary arterial hypertension

Publications

History Filter Activity

8 Aug 2023, Gel status: 1

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: SMAD4 were changed from Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome MIM#175050; Pulmonary arterial hypertension to Pulmonary arterial hypertension MONDO:0015924, SMAD4-related

8 Aug 2023, Gel status: 1

Added Tag

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Tag disputed tag was added to gene: SMAD4.

19 Jun 2023, Gel status: 1

Entity classified by Genomics England curator

Bryony Thompson (Royal Melbourne Hospital)

Gene: smad4 has been classified as Red List (Low Evidence).

27 Jul 2020, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: smad4 has been classified as Amber List (Moderate Evidence).

28 Jan 2020, Gel status: 2

Entity classified by Genomics England curator

Bryony Thompson (Royal Melbourne Hospital)

Gene: smad4 has been classified as Amber List (Moderate Evidence).

28 Jan 2020, Gel status: 1

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Bryony Thompson (Royal Melbourne Hospital)

gene: SMAD4 was added gene: SMAD4 was added to Pulmonary Arterial Hypertension. Sources: Literature Mode of inheritance for gene: SMAD4 was set to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown Publications for gene: SMAD4 were set to 21898662 Phenotypes for gene: SMAD4 were set to Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome MIM#175050; Pulmonary arterial hypertension Review for gene: SMAD4 was set to AMBER